Skip to main content
OpenTrials

Clinical trial condition

Hemophilia B

Explore clinical trials studying Hemophilia B. Study availability and eligibility vary by location and protocol.

126 public trials 22 recruiting studies
Refine in advanced search Browse all conditions

Hemophilia B trial results

Completed

A Safety and Efficacy Extension Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B

NCT02053792

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • University of Colorado Aurora, Colorado, United States
  • Indiana Hemophilia & Thrombosis Center Inc. Indianapolis, Indiana, United States
  • Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States
  • University of Utah Salt Lake City, Utah, United States
View all 42 locations
View Trial Details
Completed

Nonacog Alfa Prophylaxis And Treatment Of Bleeding Episodes In Previously Treated Patients With Hemophilia B

NCT04286412

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Nirmal Hospital Pvt Ltd. Surat, Gujarat, India
  • K.J. Somaiya Hospital and Research Centre Mumbai, Maharashtra, India
  • Sahyadri Clinical Research & Development Centre Pune, Maharashtra, India
  • Christian Medical College and Hospital Ludhiana, Punjab, India
View Trial Details
Completed

Trial of AAV5-hFIX in Severe or Moderately Severe Hemophilia B

NCT02396342

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • uniQure Investigative Site Copenhagen, Denmark
  • uniQure Investigative Site Berlin, Germany
  • uniQure Investigative Site Frankfurt, Germany
  • uniQure Investigative Site Amsterdam, Netherlands
View Trial Details
Completed

Joint Health Study

NCT03358836

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Orthopaedic Institute for Children at University of California Los Angeles Los Angeles, California, United States
  • University of California San Diego San Diego, California, United States
  • Tulane University New Orleans, Louisiana, United States
  • Oregon Health & Science University Portland, Oregon, United States
View Trial Details
Completed

A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors

NCT03417245

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Investigational Site Number 0140 Little Rock, Arkansas, United States
  • Investigational Site Number 128 Gainesville, Florida, United States
  • Investigational Site Number 103 Tampa, Florida, United States
  • Investigational Site Number 102 Chicago, Illinois, United States
View all 64 locations
View Trial Details
Completed

A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors

NCT03417102

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Investigational Site Number 0117 Phoenix, Arizona, United States
  • Investigational Site Number 0139 Los Angeles, California, United States
  • Investigational Site Number 0135 Orange, California, United States
  • Investigational Site Number 0137 San Diego, California, United States
View all 58 locations
View Trial Details
Completed

Study to Determine the Safety and Efficacy of rFIXFc in Previously Untreated Males With Severe Hemophilia B

NCT02234310

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Research Site Sacramento, California, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Indianapolis, Indiana, United States
View all 27 locations
View Trial Details
Completed

Long-Term Safety, Tolerability, and Efficacy of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B

NCT02971969

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • UF CRC - Clinical Research Center Gainesville, Florida, United States
  • University of Michigan Hospital and Health Systems Ann Arbor, Michigan, United States
  • Haemophilia, Haemostasis & Thrombosis Centre Basingstoke, Hampshire, United Kingdom
View Trial Details
Completed

Global Epidemiologic Study of Preexisting Immunity to AAV in Adults With Severe Hemophilia

NCT03185897

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Orthopaedic Hemophilia Treatment Center Los Angeles, California, United States
  • University of Colorado Hemophilia & Thrombosis Center Aurora, Colorado, United States
  • Michigan State University East Lansing, Michigan, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View all 23 locations
View Trial Details
Completed

Study of Coagulation Faction VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia

NCT04072237

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +12 more
Locations
  • Medical Center "Hippocrates - N" Plovdiv, Bulgaria
  • Specialized Hospital for Active Treatment of Hematological Diseases Sofia, Bulgaria
  • Kirov Research Institute of Hematology and Blood Transfusion Kirov, Russia
  • National Medical Hematology Research Center Moscow, Russia
View Trial Details

Related conditions